natgillin/translations-raw huggingface dataset:
Sofosbuvir is approximately 61-65% bound to human plasma proteins and the binding is independent of drug concentration over the range of 1 μg/mL to 20 μg/mL.
Vezava sofosbuvirja na humane beljakovine v plazmi je približno 61–65 %, ni pa odvisna od koncentracije zdravila v razponu 1–20 μg/ml.
Sofosbuvir is not a substrate for hepatic uptake transporters, organic anion-transporting polypeptide (OATP) 1B1 or 1B3, and organic cation transporter (OCT) 1.
Sofosbuvir ni substrat za jetrne privzemne prenašalce, transportni polipeptid organskih anionov (OATP, organic anion-transporting polypeptide) 1B1 ali 1B3 in prenašalca organskih kationov (OCT, organic cation transporter) 1.
Sofosbuvir metabolite GS-331007: AUC: ↑ 48%
presnovek sofosbuvirja GS-331007: AUC: ↑ 48
Sofosbuvir metabolite GS-331007: AUC: ↑ 8%
presnovek sofosbuvirja GS-331007: AUC: ↑ 8
Sofosbuvir metabolite GS-566500: AUC: ↔
presnovek sofosbuvirja GS-566500: AUC: ↔
Sofosbuvir was studied in an open-label clinical study evaluating the safety and efficacy of 12 or 24 weeks of treatment with sofosbuvir and ribavirin in subjects with genotype 1, 2 or 3 chronic hepatitis C co-infected with HIV-1.
Sofosbuvir so preučili v odprti klinični študiji, v kateri so ocenjevali varnost in učinkovitost 12- ali 24-tedenskega zdravljenja s sofosbuvirjem in ribavirinom pri bolnikih s kroničnim hepatitisom C genotipa 1, 2 ali 3, sočasno okuženih z virusom HIV-1.
Sofosbuvir was studied in an open-label clinical study evaluating the safety and efficacy of 24 weeks of treatment with sofosbuvir and ribavirin in liver transplant recipients with chronic hepatitis C. Eligible subjects were ≥18 years old and had undergone liver transplantation 6 to 150 months prior to screening.
Sofosbuvir so preučili v odprti klinični študiji, v kateri so ocenjevali varnost in učinkovitost 24- tedenskega zdravljenja s sofosbuvirjem in ribavirinom pri prejemnikih presajenih jeter s kroničnim hepatitisom C. Primerne osebe so bile stare ≥ 18 let in so imele presaditev jeter 6 do 150 mesecev pred presejanjem.
Sofosbuvir/Tenofovir disoproxil fumarate
ofosbuvir/dizoproksiltenofovirijev fumarat
Sofosbuvir:
dizoproksiltenofoviratom,
Sofosbuvir:
in farmakokinetičnim
Sofosbuvir: AUC: ↑ 36%
sofosbuvir: AUC: ↑ 36
Sofosbuvir: AUC: ↔
Najmanjše koncentracije
Soft capsule
Mehka kapsula
Soft swelling generally resolved by week 6 postoperatively
mehka oteklina, ki na splošno izgine do 6. tedna po operaciji
Soft Tissue Sarcoma (STS)
Sarkom mehkih tkiv (STS)
soft-tissue sarcoma.
sarkom mehkega tkiva.
softening of the bones (with bone pain and sometimes resulting in fractures), which may occur due to damage to kidney tubule cells
mehčanje kosti (z bolečinami v kosteh, včasih tudi zlom), ki se lahko pojavijo zaradi okvare celic ledvičnih tubulov
Solicited adverse reaction within 5 days postvaccination.
2neželeni učinki v 5 dneh po cepljenju, o katerih niso poročali spontano
Solid and haematopoietic malignancies (excluding skin cancers)
Čvrste in hematopoetične maligne bolezni (razen kožnega raka)
Solid tumour patients: in a larger cohort of 929 patients with solid tumours (including breast cancer and ovarian cancer) predominantly treated at a dose of 50 mg/m2 every 4 weeks, the safety profile and incidence of adverse effects are comparable to those of the patients treated in the pivotal breast cancer and ovarian cancer trials.
Bolnice s solidnimi tumorji: v večji kohorti 929 bolnikov s solidnimi tumorji (vključno z rakom dojk in rakom jajčnikov), ki so jih zdravili pretežno z odmerkom 50 mg/m2 vsake 4 tedne, sta bila profil neželenih učinkov zdravila in incidenca neželenih učinkov podobna kot pri bolnicah, zdravljenih v osrednjih preskušanjih raka dojk in raka jajčnikov.
Solifenacin: AUC: ↑ 3.0-fold
Solifenacin: AUC: ↑ 3,0-krat
Soliris 300 mg concentrate for solution for infusion
Soliris 300 mg koncentrat za pripravo raztopine za infundiranje
Soliris 300 mg concentrate for solution for infusion Eculizumab
Soliris 300 mg koncentrat za pripravo raztopine za infundiranje ekulizumab
Soliris contains a protein and proteins can cause allergic reactions in some people.
Zdravilo Soliris vsebuje beljakovino, beljakovine pa lahko pri nekaterih ljudeh povzročijo alergijske reakcije.
Soliris contains the active substance eculizumab and it belongs to a class of medicines called monoclonal antibodies.
Zdravilo Soliris vsebuje zdravilno učinkovino ekulizumab in spada v skupino zdravil, imenovano monoklonska protitelesa.
Soliris has no or negligible influence on the ability to drive and use machines.
Zdravilo Soliris nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Soliris has not been studied in patients with PNH who weigh less than 40kg.
Zdravila Soliris niso preučevali pri bolnikih s PNH, ki tehtajo manj kot 40 kg.
Soliris is a concentrate that is made up into a solution for infusion.
Zdravilo Soliris je koncentrat za pripravo raztopine za infundiranje.
Soliris is not recommended during pregnancy.
Zdravilo Soliris med nosečnostjo ni priporočljivo.
Soliris is presented as a concentrate for solution for infusion (30 ml in a vial – pack size of 1).
Zdravilo Soliris je na voljo kot koncentrat za pripravo raztopine za infundiranje (30 ml v viali – pakiranje po 1 vialo).
Soliris is used to treat adults and children with:
Zdravilo Soliris se uporablja za zdravljenje odraslih in otrok, ki imajo:
Soliris may pass through your breast milk to your baby.
Zdravilo Soliris lahko z materinim mlekom prehaja na vašega dojenčka.
Soliris must be administered by a healthcare professional and under the supervision of a physician experienced in the management of patients with haematological and/or renal disorders.
Zdravilo Soliris mora dajati zdravstveni delavec, sicer pod nadzorom zdravnika z izkušnjami z zdravljenjem bolnikov s hematološkimi in/ali ledvičnimi motnjami.
Soliris must be given under the supervision of a doctor who has experience in the management of patients with blood and/or kidney disorders.
Zdravilo Soliris se mora dajati pod nadzorom zdravnika, ki ima izkušnje z zdravljenjem bolnikov s krvnimi in/ali ledvičnimi obolenji.
Soliris reduced signs of complement-mediated TMA activity, as shown by an increase in mean platelet counts from baseline to 26 weeks.
Zdravilo Soliris je zmanjšalo znake aktivnosti TMA, posredovane s komplementom, kot kaže zvečanje povprečnega števila trombocitov od izhodišča do
Soliris should only be administered via intravenous infusion.
Zdravilo Soliris se daje samo kot intravenska infuzija.
Soliris treatment is recommended to continue for the patient’s lifetime, unless the discontinuation of Soliris is clinically indicated (see section 4.4).
Priporočeno je, da se bolnik z zdravilom Soliris zdravi celo življenje, razen če je prekinitev zdravljenja z zdravilom Soliris klinično indicirana (glejte poglavje 4.4).
Soliris treatment may reduce your natural resistance to infections, especially against certain organisms that cause meningitis (infection of the linings of the brain).
Zdravljenje z zdravilom Soliris lahko zmanjša vašo naravno odpornost proti okužbam, še posebno proti določenim organizmom, ki povzročajo meningitis (okužba možganskih ovojnic).
Soliris was administered as an intravenous infusion over 25 – 45 minutes.
Zdravilo Soliris je bilo aplicirano v obliki 25 - 45-minutne intravenske infuzije.
Soliris was compared with placebo (a dummy treatment).
Zdravilo Soliris so primerjali s placebom (zdravilom brez zdravilne učinkovine).
Soliris was more effective than placebo in improving the symptoms of PNH.
Zdravilo Soliris je bilo pri izboljšanju simptomov paroksizmalne nočne hemoglobinurije učinkovitejše od placeba.
Soliris was studied in one main study involving 87 adults with PNH who had had at least four blood transfusions for anaemia in the previous year.
Zdravilo Soliris so proučevali v eni glavni študiji s 87 odraslimi bolniki s paroksizmalno nočno hemoglobinurijo, ki so v preteklem letu zaradi slabokrvnosti prejeli najmanj štiri transfuzije krvi.
Soliris was studied in three main studies involving 67 patients with aHUS.
Zdravilo Soliris so proučevali v treh glavnih študijah, ki so vključevale 67 bolnikov z aHUS.
SoloStar 1 pen
SoloStar 1 injekcijski peresnik
SoloStar is a pre-filled pen for the injection of insulin.
SoloStar je napolnjen injekcijski peresnik, namenjen za injiciranje insulina.
SoloStar must never be used if it is damaged or if the patient is not sure if it is working properly.
Ne uporabljajte SoloStarja, če je poškodovan ali če niste prepričani, da deluje pravilno.
SoloStar must never be used if it is damaged or if the patient is not sure if it is working properly.
SoloStarja ne sme uporabljati SoloStarja, če je poškodovan ali če ni prepričan, da deluje pravilno.
SoloStar must never be used if it is damaged or if the patient is not sure if it is working properly.
SoloStarja ne sme uporabljati, če je poškodovan ali če ni prepričan, da deluje pravilno.
Soluble tablet
tableta za peroralno raztopino
Soluble tablet.
Tableta za peroralno raztopino.
Solution
Liprolog
SOLUTION (STABILISER) VIAL
VIALA Z RAZTOPINO (STABILIZATORJEM)
Solution for
raztopina za
Solution for
raztopina za injiciranje
Solution for
ubkutana
Solution for dispersion for injection or infusion
raztopina za disperzijo za injiciranje ali infundiranje
solution for infusion
EU/1/09/550/009
Solution for infusion
Raztopina za
Solution for infusion
Raztopina za infundiranje.
Solution for infusion
Raztopina za intravensko infundiranje
solution for infusion
raztopino za
solution for infusion
raztopino za infundiranje
Solution for infusion (infusion).
Raztopina za infundiranje (infuzija).
Solution for infusion 1 bottle of 100 ml
raztopina za infundiranje 1 steklenica s 100 ml
Solution for infusion 1 bottle of 100 ml.
raztopina za infundiranje ena plastenka s 100 ml
Solution for infusion 1 bottle, 100 ml
raztopina za infundiranje 1 plastenka, 100 ml
Solution for infusion 250 mg/50 ml
Raztopina za infundiranje 250 mg/50 ml
Solution for infusion 4,000 IU/10 ml
Raztopina za infundiranje 4,000 i.e./10 ml
Solution for infusion 5 g / 50 ml
raztopina za infundiranje 5 g /50 ml
Solution for infusion 6 x 50 ml vials
Raztopina za infundiranje 6 vial x 50 ml
Solution for infusion Clear, colourless solution.
raztopina za infundiranje bistra in brezbarvna raztopina
solution for infusion Concentrate for
koncentrat za
solution for infusion Concentrate for
raztopino za infundiranje koncentrat za
Solution for infusion Oral solution
raztopina za infundiranje peroralna raztopina
solution for infusion Powder for concentrate for
raztopino za infundiranje prašek za koncentrat za
solution for infusion Solution for
raztopina za
solution for infusion Solution for
raztopino za infundiranje raztopina za
Solution for infusion Solution for infusion
uspenzija za injiciranje
Solution for infusion.
Raztopina za infundiranje
Solution for injection
EU/1/98/067/003
Solution for injection
injiciranje
Solution for injection
injiciranje Raztopina za
Solution for injection
injiciranje Raztopina za injiciranje Raztopina za
Solution for injection
Izmišljeno
Solution for injection
Raztopina za injiciranje Raztopina za
Solution for injection
raztopina za injiciranje raztopina za injiciranje
Solution for injection
Raztopina za injiciranje.
Solution for injection
Raztopina za injiciranje/ infundiranje
Solution for injection
raztopina za injicoranje
solution for injection
raztopino za injiciranje
Solution for injection
suspenzija za injiciranje
Solution for injection
uspenzija za injiciranje
solution for injection
za raztopino za injiciranje
Solution for injection (6.75 mg/0.9 ml)
raztopina za injiciranje (6,75 mg/0,9 ml)
Solution for injection (injection)
Raztopina za injiciranje (injekcija).
Solution for injection (injection) (Sureclick).
Raztopina za injiciranje (injekcija) (SureClick).
Solution for injection (injection) Clear, colourless solution.
raztopina za injiciranje (injekcija) Bistra, brezbarvna raztopina.
Solution for injection (injection) in a pre-filled pen.
Raztopina za injiciranje (injekcija) v napolnjenem injekcijskem peresniku (SureClick).
Solution for injection (injection) in pre-filled syringe.
raztopina za injiciranje (injekcija) v napolnjeni injekcijski brizgi
Solution for injection (injection).
Raztopina za injiciranje (injekcijo).
Solution for injection (injection).
Raztopina za injiciranje (injiciranje)
Solution for injection (Penfill)
raztopina za injiciranje (Penfill)
Solution for injection - Pack of 10 doses:
Raztopina za injiciranje – škatla z 10 odmerki:
Solution for injection 1 cartridge packs with 3 pen needles
raztopina za injiciranje 1 vložek pakiranja s 3 iglami za peresnik
Solution for injection 1 cartridge packs with 3 pen needles
raztopina za injiciranje 1 vložek pakiranji s 3 iglami za peresnik
Solution for injection 1 pen of 3 ml
raztopina za injiciranje
Solution for Injection 1 vial (312 IU/1ml)
Raztopina za injiciranje 1 viala (312 i.e./1 ml)
Solution for injection 1 vial (6.75 mg/0.9 ml)
raztopina za injiciranje 1 viala (6,75 mg/0,9 ml)
Solution for injection 1 vial contains Volume: {Z} mL
Raztopina za injiciranje Ena viala vsebuje Prostornina: {Z} ml
Solution for injection 1 vial of 10 ml
Raztopina za injiciranje 1 viala z 10 ml.
Solution for injection 1 vial of 5 ml. vials of 5 ml.
raztopina za injiciranje 1 viala s 5 ml. viali s 5 ml.
Solution for injection 1 vial.
raztopina za injiciranje 1 viala.
Solution for injection 1 x 0.5 ml
raztopina za injiciranje 1 x 0,5 ml
Solution for injection 1 x 1 ml
raztopina za injiciranje 1 x 1 ml
Solution for injection 1 x 5 ml vial
raztopina za injiciranje 1 x viala 5 ml
Solution for injection 1400 mg/11.7 mL
raztopina za injiciranje 1400 mg/11,7 ml
Solution for injection 1600 mg/13.4 mL
raztopina za injiciranje 1600 mg/13,4 ml
Solution for injection 4 cartridges of 3 ml.
raztopina za injiciranje 4 vložki s 3 ml.
solution for injection 4 vials
raztopina za injiciranje 4 viale
Solution for injection 5 x 1.6 ml cartridges
raztopina za injiciranje 5 x 1,6 ml vložki
Solution for injection 6 ampoules
raztopina za injiciranje 6 ampul
Solution for injection 6 mL
raztopina za injiciranje 6 ml
Solution for injection Clear colourless solution
Raztopina za injiciranje Prozorna brezbarvna raztopina
Solution for injection Clear, colourless solution
Raztopina za injiciranje Bistra, brezbarvna raztopina
Solution for injection Clear, colourless solution.
raztopina za injiciranje bistra brezbarvna raztopina
Solution for injection in
raztopina za
Solution for injection in
Raztopina za injiciranje
Solution for injection in
raztopina za injiciranje v
Solution for injection in a
Raztopina za injiciranje
Solution for injection in a cartridge for OptiClik.
Raztopina za injiciranje v vložku za injekcijski peresnik OptiClik.
Solution for injection in a cartridge for OptiClik.
Raztopina za injiciranje v vložku za OptiClick.
Solution for injection in a cartridge for OptiClik.
Raztopina za injiciranje v vložku za OptiClik.
Solution for injection in a cartridge for SurePal 10.
Raztopina za injiciranje v vložku za injekcijski peresnik SurePal 10.
Solution for injection in a cartridge for SurePal 15.
Raztopina za injiciranje v vložku za injekcijski peresnik SurePal 15.
Solution for injection in a cartridge for SurePal 5.
Raztopina za injiciranje v vložku za injekcijski peresnik SurePal 5.
Solution for injection in a cartridge.
Raztopina za injiciranje v vložku 3 vložki s 3 ml
Solution for injection in a pre-filled pen
raztopina za injiciranje v napolnjenem injekcijskem peresniku
Solution for injection in a pre-filled pen (AutoClicks) 2 AutoClicks pre-filled pens
raztopina za injiciranje v napolnjenem injekcijskem peresniku (AutoClicks) 2 napolnjena injekcijska peresnika
Solution for injection in a pre-filled pen (AutoClicks) 2 AutoClicks pre-filled pens
raztopina za injiciranje v napolnjenem injekcijskem peresniku (AutoClicks) 2 napolnjena injekcijska peresnika AutoClicks
Solution for injection in a pre-filled pen (SureClick).
Raztopina za injiciranje (injekcijo) v napolnjenem injekcijskem peresniku (SureClick).
Solution for injection in a pre-filled pen 4 pre-filled pens
raztopina za injiciranje v napolnjenem injekcijskem peresniku 4 napolnjeni injekcijski peresniki
Solution for injection in a pre-filled pen, OptiSet.
Raztopina za injiciranje v napolnjenem injekcijskem peresniku OptiSet.
Solution for injection in a single use pre-filled pen (0.6 ml).
Raztopina za injiciranje v napolnjenem injekcijskem peresniku (0,6 ml) za enkratno uporabo.
Solution for injection in a single-dose vial.
Raztopina za injiciranje v enoodmerni viali.
Solution for injection in a vial
raztopina za injiciranje v viali
Solution for injection in a vial.
Raztopina za injiciranje v viali 1 viala s 5 ml
Solution for injection in cartridge.
raztopina za injiciranje v vložku
Solution for injection in pre- filled pen
raztopina za injiciranje v napolnjenem peresniku
Solution for injection in pre- filled syringe
raztopina za injiciranje v napolnjeni brizgi
Solution for injection in pre- filled syringe
raztopina za injiciranje v napolnjeni injekcijski brizgi
Solution for injection in pre-filled pen (ClickJect)
raztopina za injiciranje v napolnjenem injekcijskem peresniku (ClickJect)
Solution for injection in pre-filled pen (ClickJect) 4 ClickJect pre-filled pens
raztopina za injiciranje v napolnjenem injekcijskem peresniku (ClickJect) 4 ClickJect napolnjeni injekcijski peresniki
Solution for injection in pre-filled pen (injection), SmartJect
raztopina za injiciranje v napolnjenem injekcijskem peresniku (injekcija), SmartJect raztopina za injiciranje v napolnjeni injekcijski brizgi (injekcija)
Solution for injection in pre-filled pen (injection).
Raztopina za injiciranje v napolnjenem (injekcijskem) peresniku
Solution for injection in pre-filled pen (SensoReady pen) The solution is clear and colourless to slightly yellow.
raztopina za injiciranje v napolnjenem injekcijskem peresniku (injekcijskem peresniku SensoReady) Raztopina je bistra in brezbarvna do nekoliko rumenkasta.
Solution for injection in pre-filled pen (Smartject) 1 pre-filled pen
NALEPKA ZA NAPOLNJEN INJEKCIJSKI PERESNIK
Solution for injection in pre-filled pen (Smartject) 1 pre-filled pen
raztopina za injiciranje v napolnjenem injekcijskem peresniku (Smartject) 1 napolnjen injekcijski peresnik
Solution for injection in pre-filled pen (SmartJect) Multipack: 3 (3 packs of 1) pre-filled pens
raztopina za injiciranje v napolnjenem injekcijskem peresniku (SmartJect) Večkratno pakiranje: 3 napolnjeni injekcijski peresniki (3 enojna pakiranja)
Solution for injection in pre-filled pen (SmartJect) Multipack: 3 (3 packs of 1) pre-filled pens
raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga
Solution for injection in pre-filled pen.
raztopina za injiciranje v napolnjenem injekcijskem peresniku
Solution for injection in pre-filled syringe
Raztopina za injiciranje v napolnjeni injekcijski brizgi.
Solution for injection in pre-filled syringe (injection) The solution is clear and colourless to slightly yellow.
raztopina za injiciranje v napolnjeni injekcijski brizgi (injekcija) Raztopina je bistra in brezbarvna do nekoliko rumenkasta.
Solution for injection in pre-filled syringe 1 GRADUATED pre-filled syringe
raztopina za injiciranje v napolnjeni injekcijski brizgi 1 ODMERNA napolnjena injekcijska brizga
Solution for injection in pre-filled syringe 1 pre-filled syringe
raztopina za injiciranje v napolnjeni injekcijski brizgi
Solution for injection in pre-filled syringe 1 pre-filled syringe pre-filled syringes
Raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga napolnjenih injekcijskih brizg
Solution for injection in pre-filled syringe 1 pre-filled syringe with needle guard
raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z varovalom za iglo
Solution for injection in pre-filled syringe 2 pre-filled syringes
raztopina za injiciranje v napolnjeni injekcijski brizgi 2 napolnjeni injekcijski brizgi
Solution for injection in pre-filled syringe 2 single-use pre-filled syringes
raztopina za injiciranje v napolnjeni injekcijski brizgi 2 napolnjeni injekcijski brizgi
Solution for injection in pre-filled syringe 4 pre-filled syringes
raztopina za injiciranje v napolnjeni injekcijski brizgi 4 napolnjene injekcijske brizge
Solution for injection in pre-filled syringe 4 pre-filled syringes with needle guard
raztopina za injiciranje v napolnjeni injekcijski brizgi 4 napolnjene injekcijske brizge z varovalom za iglo
Solution for injection in pre-filled syringe 7 GRADUATED pre-filled syringes
raztopina za injiciranje v napolnjeni injekcijski brizgi 7 ODMERNIH napolnjenih injekcijskih brizg
Solution for injection in pre-filled syringe 7 pre-filled syringes
Raztopina za iniciranje v napolnjeni injekcijski brizgi 7 napolnjenih injekcijskih brizg
Solution for injection in pre-filled syringe with needleguard.
Raztopina za injiciranje v napolnjeni injekcijski brizgi s ščitnikom za iglo
Solution for injection in pre-filled syringe.
raztopina za injiciranje v napolnjeni injekcijski brizgi
Solution for injection in pre-filled syringe: Roche Pharma AG
Raztopina za injiciranje v napolnjeni injekcijski brizgi: Roche Pharma AG
Solution for injection in prefilled pen.
Raztopina za injiciranje v napolnjenem injekcijskem peresniku.
Solution for injection in vial 15 ml
raztopina za injiciranje v viali 15 ml
Solution for injection One multi-dose vial
raztopina za injiciranje Ena večodmerna viala
Solution for injection One multidose vial Customer ref
raztopina za injiciranje Ena večodmerna viala Ref.
Solution for injection or
Raztopina za injiciranje ali
Solution for injection or infusion
Raztopina za injiciranje ali infundiranje
Solution for injection or infusion
raztopina za injiciranje ali infundiranje.
Solution for injection or infusion 1 pre-filled syringe with 0.8 ml
raztopina za injiciranje ali infundiranje 1 napolnjena injekcijska brizga z 0,8 ml
Solution for injection or infusion 10 pre-filled syringes with 0.5 ml
raztopina za injiciranje ali infundiranje 10 napolnjenih injekcijskih brizg z 0,5 ml
Solution for injection or infusion 10 pre-filled syringes with 0.8 ml
raztopina za injiciranje ali infundiranje 10 napolnjenih injekcijskih brizg z 0,8 ml
Solution for injection or infusion 5 pre-filled syringes containing 0.8 mL.
raztopina za injiciranje ali infundiranje 5 napolnjenih injekcijskih brizg, ki vsebujejo 0,8 ml.
Solution for injection or infusion 5 pre-filled syringes with 0.5 ml
raztopina za injiciranje ali infundiranje 5 napolnjenih injekcijskih brizg z 0,5 ml
Solution for injection or infusion 5 pre-filled syringes with 0.8 ml
raztopina za injiciranje ali infundiranje 5 napolnjenih injekcijskih brizg z 0,8 ml
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.5 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje: 10 (2 pakiranji po 5) napolnjenih injekcijskih brizg, ki vsebujejo 0,5 ml
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.5 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje: 10 (2 pakiranji po 5) napolnjenih injekcijskih brizg, ki vsebujejo 0,5 ml.
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.5 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje:10 (2 pakiranji po 5) napolnjenih injekcijskih brizg, ki vsebujejo 0,5 ml.
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.8 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje: 10 (2 pakiranji po 5) napolnjenih injekcijskih brizg, ki vsebujejo 0,8 ml
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.8 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje: 10 (2 pakiranji po 5) napolnjenih injekcijskih, ki vsebujejo 0,8 ml.
Solution for injection or infusion Multipack: 10 (2 packs of 5) pre-filled syringes containing 0.8 mL.
raztopina za injiciranje ali infundiranje Skupno pakiranje:10 (2 pakiranji po 5) napolnjenih injekcijskih brizg, ki vsebujejo 0,8 ml.
Solution for injection Solution for injection
raztopina za injiciranje
Solution for injection Volume: xx.x mL
raztopina za injiciranje Prostornina: xx,x ml